Drawing for INDX

USPTO serial 50210658

INDX

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with INDX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christina M. Licursi

Christina M. Licursi Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210-2206United States

Goods and services

ClassDescriptionStatusFirst use
001Chemical and biological preparations and reagents for scientific research and laboratory use in analyzing biological samples; Chemical and biological preparations and reagents for use in developing diagnostic kits, tests, and assaysACTIVE—
005Diagnostic preparations for medical purposes, namely, chemical and biological reagents for use in diagnostic kits, tests, and assays; Diagnostic test kits comprising chemical and biological reagents for medical diagnostic use; Chemical and biological diagnostic reagents and preparations for medical purposes, for analyzing biological samplesACTIVE—
009Downloadable software for use in drug discovery and development, namely, software for analyzing and managing biological, chemical, and clinical data; Downloadable software using artificial intelligence for analyzing extracellular vesicle data for scientific research and diagnostic purposes; Downloadable software and downloadable mobile applications for use with diagnostic instruments, tests, and kits, namely, software for receiving, analyzing, and displaying diagnostic test dataACTIVE—
042Scientific research and development services in the field of extracellular vesicles; Research and development services in the field of drug discovery and drug development; Pharmaceutical drug development services; Scientific laboratory services, namely, isolation, fractionation, and analysis of extracellular vesicles from biological samples, for research and diagnostic development purposes; Providing temporary use of online non-downloadable software for use in drug discovery and development, namely, software for analyzing and managing biological, chemical, and clinical data; Providing temporary use of online non-downloadable software using artificial intelligence for analyzing extracellular vesicle data for scientific research and diagnostic purposes; Platform as a service (PaaS) featuring computer software platforms for isolating, fractionating, and analyzing extracellular vesicles and for analyzing the resulting data in the fields of drug development, scientific research, and diagnostics; Research and development services in the field of diagnostics, including diagnostic tests, assays, and kitsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 10, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 10, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance